Skinvisible Stock Performance
| SKVI Stock | USD 0.23 0.12 34.29% |
Skinvisible holds a performance score of 8 on a scale of zero to a hundred. The entity has a beta of -5.13, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Skinvisible are expected to decrease by larger amounts. On the other hand, during market turmoil, Skinvisible is expected to outperform it. Use Skinvisible treynor ratio and the relationship between the semi variance and relative strength index , to analyze future returns on Skinvisible.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Skinvisible are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite fairly fragile basic indicators, Skinvisible demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 35.9 K | |
| Total Cashflows From Investing Activities | -20.9 K | |
| Free Cash Flow | 353.7 K |
Skinvisible |
Skinvisible Relative Risk vs. Return Landscape
If you would invest 14.00 in Skinvisible on October 7, 2025 and sell it today you would earn a total of 9.00 from holding Skinvisible or generate 64.29% return on investment over 90 days. Skinvisible is currently generating 4.9675% in daily expected returns and assumes 47.7476% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Skinvisible, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Skinvisible Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Skinvisible's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Skinvisible, and traders can use it to determine the average amount a Skinvisible's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.104
| Best Portfolio | Best Equity | SKVI | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Skinvisible is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Skinvisible by adding it to a well-diversified portfolio.
Skinvisible Fundamentals Growth
Skinvisible OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Skinvisible, and Skinvisible fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Skinvisible OTC Stock performance.
| Return On Asset | 0.0678 | |||
| Profit Margin | (1.88) % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 4.03 M | |||
| Shares Outstanding | 4.54 M | |||
| Price To Earning | 4.91 X | |||
| Price To Sales | 1.38 X | |||
| Revenue | 663.43 K | |||
| EBITDA | 158.23 K | |||
| Cash And Equivalents | 160.34 K | |||
| Cash Per Share | 0.04 X | |||
| Total Debt | 2.58 M | |||
| Debt To Equity | (1.07) % | |||
| Book Value Per Share | (1.38) X | |||
| Cash Flow From Operations | 374.61 K | |||
| Earnings Per Share | (0.19) X | |||
| Total Asset | 227.3 K | |||
| Retained Earnings | (27.83 M) | |||
| Current Asset | 97.12 K | |||
| Current Liabilities | 5.63 M | |||
About Skinvisible Performance
By evaluating Skinvisible's fundamental ratios, stakeholders can gain valuable insights into Skinvisible's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Skinvisible has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Skinvisible has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Skinvisible, Inc., together with its subsidiaries, focuses on the development, manufacture, and sale of topical, transdermal, and mucosal polymer-based delivery system technologies and formulations for use in pharmaceutical, over the counter, personal skincare, and cosmetic arenas. Skinvisible, Inc. was incorporated in 1998 and is based in Las Vegas, Nevada. Skinvisible operates under Household Personal Products classification in the United States and is traded on OTC Exchange. It employs 2 people.Things to note about Skinvisible performance evaluation
Checking the ongoing alerts about Skinvisible for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Skinvisible help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Skinvisible is way too risky over 90 days horizon | |
| Skinvisible has some characteristics of a very speculative penny stock | |
| Skinvisible appears to be risky and price may revert if volatility continues | |
| Skinvisible currently holds 2.58 M in liabilities. Skinvisible has a current ratio of 0.05, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Skinvisible until it has trouble settling it off, either with new capital or with free cash flow. So, Skinvisible's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Skinvisible sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Skinvisible to invest in growth at high rates of return. When we think about Skinvisible's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 663.43 K. Net Loss for the year was (1.07 M) with profit before overhead, payroll, taxes, and interest of 660.13 K. | |
| Latest headline from thelincolnianonline.com: Voya Investment Management LLC Increases Position in United Rentals, Inc. URI |
- Analyzing Skinvisible's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Skinvisible's stock is overvalued or undervalued compared to its peers.
- Examining Skinvisible's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Skinvisible's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Skinvisible's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Skinvisible's otc stock. These opinions can provide insight into Skinvisible's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Skinvisible OTC Stock analysis
When running Skinvisible's price analysis, check to measure Skinvisible's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Skinvisible is operating at the current time. Most of Skinvisible's value examination focuses on studying past and present price action to predict the probability of Skinvisible's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Skinvisible's price. Additionally, you may evaluate how the addition of Skinvisible to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |